IBDEI2TK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47329,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47329,1,4,0)
 ;;=4^C82.15
 ;;^UTILITY(U,$J,358.3,47329,2)
 ;;=^5001476
 ;;^UTILITY(U,$J,358.3,47330,0)
 ;;=C82.16^^209^2346^155
 ;;^UTILITY(U,$J,358.3,47330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47330,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47330,1,4,0)
 ;;=4^C82.16
 ;;^UTILITY(U,$J,358.3,47330,2)
 ;;=^5001477
 ;;^UTILITY(U,$J,358.3,47331,0)
 ;;=C82.17^^209^2346^158
 ;;^UTILITY(U,$J,358.3,47331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47331,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Spleen
 ;;^UTILITY(U,$J,358.3,47331,1,4,0)
 ;;=4^C82.17
 ;;^UTILITY(U,$J,358.3,47331,2)
 ;;=^5001478
 ;;^UTILITY(U,$J,358.3,47332,0)
 ;;=C82.18^^209^2346^157
 ;;^UTILITY(U,$J,358.3,47332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47332,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47332,1,4,0)
 ;;=4^C82.18
 ;;^UTILITY(U,$J,358.3,47332,2)
 ;;=^5001479
 ;;^UTILITY(U,$J,358.3,47333,0)
 ;;=C82.19^^209^2346^151
 ;;^UTILITY(U,$J,358.3,47333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47333,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47333,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,47333,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,47334,0)
 ;;=C82.20^^209^2346^169
 ;;^UTILITY(U,$J,358.3,47334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47334,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Uspec Site
 ;;^UTILITY(U,$J,358.3,47334,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,47334,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,47335,0)
 ;;=C82.21^^209^2346^162
 ;;^UTILITY(U,$J,358.3,47335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47335,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47335,1,4,0)
 ;;=4^C82.21
 ;;^UTILITY(U,$J,358.3,47335,2)
 ;;=^5001482
 ;;^UTILITY(U,$J,358.3,47336,0)
 ;;=C82.23^^209^2346^164
 ;;^UTILITY(U,$J,358.3,47336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47336,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47336,1,4,0)
 ;;=4^C82.23
 ;;^UTILITY(U,$J,358.3,47336,2)
 ;;=^5001484
 ;;^UTILITY(U,$J,358.3,47337,0)
 ;;=C82.22^^209^2346^166
 ;;^UTILITY(U,$J,358.3,47337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47337,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47337,1,4,0)
 ;;=4^C82.22
 ;;^UTILITY(U,$J,358.3,47337,2)
 ;;=^5001483
 ;;^UTILITY(U,$J,358.3,47338,0)
 ;;=C82.24^^209^2346^160
 ;;^UTILITY(U,$J,358.3,47338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47338,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47338,1,4,0)
 ;;=4^C82.24
 ;;^UTILITY(U,$J,358.3,47338,2)
 ;;=^5001485
 ;;^UTILITY(U,$J,358.3,47339,0)
 ;;=C82.25^^209^2346^163
 ;;^UTILITY(U,$J,358.3,47339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47339,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47339,1,4,0)
 ;;=4^C82.25
 ;;^UTILITY(U,$J,358.3,47339,2)
 ;;=^5001486
 ;;^UTILITY(U,$J,358.3,47340,0)
 ;;=C82.26^^209^2346^165
 ;;^UTILITY(U,$J,358.3,47340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47340,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47340,1,4,0)
 ;;=4^C82.26
 ;;^UTILITY(U,$J,358.3,47340,2)
 ;;=^5001487
 ;;^UTILITY(U,$J,358.3,47341,0)
 ;;=C82.27^^209^2346^168
 ;;^UTILITY(U,$J,358.3,47341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47341,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Spleen
